期刊文献+

氟尿嘧啶3种原位形成植入体的体外释放度研究 被引量:1

Studies on in vitro Release of Three In-situ Forming Implants Containing 5-Fluorouracil
下载PDF
导出
摘要 目的:考察处方和制备工艺对氟尿嘧啶(5-FU)3种原位形成植入体释药速度的影响。方法:以单甲基聚乙二醇-羟基乙酸共聚物(mPEG-PLGA)为材料制备温敏性凝胶,以聚乙二醇/乳酸羟基乙酸共聚物(PLGA-PEG-PLGA)为材料制备原位形成凝胶剂,原位形成微球分别以PLGA-PEG-PLGA、聚乳酸(PLA)、端羧基聚乳酸-羟基乙酸共聚物(PLGA-C00H)为材料制备。采用UV法通过透析袋法测定体外释放度。结果:聚合物的浓度是影响原位植入体体外释放度的主要因素。除此外对于原位微球剂来说,N-甲基吡咯烷酮(NMP)和油相的比例也是影响体外释放度的重要因素之一。3种原位形成植入体主要通过扩散机制释药,其中温敏性凝胶的释药速度最快,原位微球剂与原位形成凝胶剂相比,突释减小,释药速度降低。结论:原位微球剂的控释效果最理想,值得进一步研究。 Objective: To examine the effects of formulation factors on in vitro release rate of three in-situ forming implants contai- ning 5-fluorouracil (5-FU). Method: Thermosensitive hydrogel was prepared with mPEG-PLGA and in-situ forming hydrogel was pre- pared with PLGA-PEG-PLGA. Three kinds of polymers, namely PLGA-PEG-PLGA, PLA and PLGA-COOH were used to prepare in-situ forming microspheres. In vitro release rate was determined by UV through dialysis bag method. Result: The polymer concentration was the main factor to influence in vitro release of in-situ forming implants containing 5-FU. The volume ratio of NMP and oil phase was also the important factor to affect drug release rate of in-situ forming microspheres. Drug release from the three in-situ forming implants was accorded with diffusion mechanism. In vitro release rate of thermosensitive hydrogel was the quickest and in-situ forming microspheres had less burst-effect and more stable release rate compared with in-situ forming hydrogel. Conclusion: In-situ forming microspheres have more desirable controlled effects and are deserved to be investigated further.
出处 《中国药师》 CAS 2011年第5期602-605,共4页 China Pharmacist
基金 全军十一五青年基金(编号:06Q033)
关键词 氟尿嘧啶 原位微球 温敏性凝胶 原位形成 5-fluorouracil In-situ microspheres Thermosensitive hydrogels In-situ forming
  • 相关文献

参考文献6

  • 1Guidetti B,Azéma J,Malet-Martino M,et al.Delivery systems for the treatment of proliferative vitreoretinopathy:materials,devices and colloidal carriers[J].Curr Drug Deliv,2008,5(1):7-19.
  • 2Kranz H,Bodmeier R.Structure formation and characterization of injectable drug loaded biodegradable devices:in situ implants versus in situ microparticles[J].Eur J Pharm Sci,2008,34(2-3):164-172.
  • 3Kranz H,Bodmeier R.A novel in situ forming drug delivery system for controlled parenteral drug delivery[J].Int J Pharm,2007,332(1-2):107-114.
  • 4Duwuri S,Janoria KG,Mitra AK.Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir[J].J Control Release,2005,108 (2-3):282-293.
  • 5Jcong B,Bae YH,Kim SW.Thermoreversible gelation of PEG-PLGA-PEG triblock copolymcr aqueous solutions[J].Macromolecules,1999,32(21):7064-7069.
  • 6蒋智清,林友文,陈兰妹.氟尿嘧啶微球体外释药的影响因素[J].福建医科大学学报,2006,40(4):364-367. 被引量:6

二级参考文献7

共引文献5

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部